Premier Health & Rehabilitation Center Of Lv, Lp | |
2945 Casa Vegas Street, Las Vegas, Nevada 89169 | |
(702) 735-7179 | |
Name | Premier Health & Rehabilitation Center Of Lv, Lp |
---|---|
Location | 2945 Casa Vegas Street, Las Vegas, Nevada |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 100 |
Occupancy Rate | 65.2% |
Medicare ID (CCN) | 295021 |
Legal Business Name | Premier Health And Rehabilitation Center Of Las Vegas, Lp |
Ownership Type | For Profit - Partnership |
NPI Number | 1235330242 |
Organization Name | THI OF NEVADA AT VEGAS VALLEY, LLC |
Doing Business As | SOUTHERN NEVADA MEDICAL AND REHABILITATION CENTER |
Address | 2945 Casa Vegas St, Las Vegas, NV 89109 |
Phone Number | 702-735-7179 |
News Archive
Those who faithfully brush their teeth each morning and night might feel as though they're doing enough to achieve a healthy smile. However, even people with good oral care habits may hear from their dentist or hygienist that they have signs of gingivitis, an early form of gum disease.
No one is safe from mental illness; it strikes without regard for age, gender, or social status. And even though one in four Canadians suffer from a mental illness, it remains a stigma, shrouded in misconceptions.
Chay Enterprises, Inc. is pleased to announce today that the company has merged with DMI Life Sciences, Inc to form Ampio Pharmaceuticals, Inc. Ampio Pharmaceuticals will trade on the NASDAQ BB under the symbol CHYE. "We have asked FINRA to change our symbol," said Don Wingerter, Ampio Pharmaceuticals' CEO, "and expect to be trading under our new symbol in less than thirty days."
A genetic mutation was found to be associated with Crohn's disease. The discovery was made by international research collaboration and was published in the prestigious journal Science Translational Medicine.
Shire plc, the global specialty biopharmaceutical company, today announced new findings on once-daily INTUNIV (guanfacine) Extended Release Tablets, the first selective alpha-2A agonist approved for the treatment of Attention Deficit Hyperactivity Disorder, at a major psychiatric meeting.
› Verified 6 days ago
NPI Number | 1558458745 |
Organization Name | THI OF NEVADA AT VEGAS VALLEY, LLC |
Doing Business As | SOUTHERN NEVADA MEDICAL AND REHABILITATION CENTER |
Address | 2945 Casa Vegas St, Las Vegas, NV 89109 |
Phone Number | 702-735-7179 |
News Archive
Those who faithfully brush their teeth each morning and night might feel as though they're doing enough to achieve a healthy smile. However, even people with good oral care habits may hear from their dentist or hygienist that they have signs of gingivitis, an early form of gum disease.
No one is safe from mental illness; it strikes without regard for age, gender, or social status. And even though one in four Canadians suffer from a mental illness, it remains a stigma, shrouded in misconceptions.
Chay Enterprises, Inc. is pleased to announce today that the company has merged with DMI Life Sciences, Inc to form Ampio Pharmaceuticals, Inc. Ampio Pharmaceuticals will trade on the NASDAQ BB under the symbol CHYE. "We have asked FINRA to change our symbol," said Don Wingerter, Ampio Pharmaceuticals' CEO, "and expect to be trading under our new symbol in less than thirty days."
A genetic mutation was found to be associated with Crohn's disease. The discovery was made by international research collaboration and was published in the prestigious journal Science Translational Medicine.
Shire plc, the global specialty biopharmaceutical company, today announced new findings on once-daily INTUNIV (guanfacine) Extended Release Tablets, the first selective alpha-2A agonist approved for the treatment of Attention Deficit Hyperactivity Disorder, at a major psychiatric meeting.
› Verified 6 days ago
NPI Number | 1760865745 |
Organization Name | PREMIER HEALTH AND REHABILITATION CENTER OF LAS VEGAS, LP |
Address | 2945 Casa Vegas St, Las Vegas, NV 89169 |
Phone Number | 702-735-7179 |
News Archive
Those who faithfully brush their teeth each morning and night might feel as though they're doing enough to achieve a healthy smile. However, even people with good oral care habits may hear from their dentist or hygienist that they have signs of gingivitis, an early form of gum disease.
No one is safe from mental illness; it strikes without regard for age, gender, or social status. And even though one in four Canadians suffer from a mental illness, it remains a stigma, shrouded in misconceptions.
Chay Enterprises, Inc. is pleased to announce today that the company has merged with DMI Life Sciences, Inc to form Ampio Pharmaceuticals, Inc. Ampio Pharmaceuticals will trade on the NASDAQ BB under the symbol CHYE. "We have asked FINRA to change our symbol," said Don Wingerter, Ampio Pharmaceuticals' CEO, "and expect to be trading under our new symbol in less than thirty days."
A genetic mutation was found to be associated with Crohn's disease. The discovery was made by international research collaboration and was published in the prestigious journal Science Translational Medicine.
Shire plc, the global specialty biopharmaceutical company, today announced new findings on once-daily INTUNIV (guanfacine) Extended Release Tablets, the first selective alpha-2A agonist approved for the treatment of Attention Deficit Hyperactivity Disorder, at a major psychiatric meeting.
› Verified 6 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Those who faithfully brush their teeth each morning and night might feel as though they're doing enough to achieve a healthy smile. However, even people with good oral care habits may hear from their dentist or hygienist that they have signs of gingivitis, an early form of gum disease.
No one is safe from mental illness; it strikes without regard for age, gender, or social status. And even though one in four Canadians suffer from a mental illness, it remains a stigma, shrouded in misconceptions.
Chay Enterprises, Inc. is pleased to announce today that the company has merged with DMI Life Sciences, Inc to form Ampio Pharmaceuticals, Inc. Ampio Pharmaceuticals will trade on the NASDAQ BB under the symbol CHYE. "We have asked FINRA to change our symbol," said Don Wingerter, Ampio Pharmaceuticals' CEO, "and expect to be trading under our new symbol in less than thirty days."
A genetic mutation was found to be associated with Crohn's disease. The discovery was made by international research collaboration and was published in the prestigious journal Science Translational Medicine.
Shire plc, the global specialty biopharmaceutical company, today announced new findings on once-daily INTUNIV (guanfacine) Extended Release Tablets, the first selective alpha-2A agonist approved for the treatment of Attention Deficit Hyperactivity Disorder, at a major psychiatric meeting.
› Verified 6 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 1 |
Total Amount of Fines in Dollars | $650 |
Number of Payment Denials | 0 |
Total Number of Penalties | 1 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 7.34 | 14.46 |
Percentage of long-stay residents who lose too much weight | 1.21 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 46 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.47 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 0 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 1.11 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 1.57 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 11.26 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 96.09 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0.71 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 12 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 8.99 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 6.48 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 92.58 | 95.98 |
Percentage of short-stay residents who made improvements in function | 69.09 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 87.28 | 82.93 |
News Archive
Those who faithfully brush their teeth each morning and night might feel as though they're doing enough to achieve a healthy smile. However, even people with good oral care habits may hear from their dentist or hygienist that they have signs of gingivitis, an early form of gum disease.
No one is safe from mental illness; it strikes without regard for age, gender, or social status. And even though one in four Canadians suffer from a mental illness, it remains a stigma, shrouded in misconceptions.
Chay Enterprises, Inc. is pleased to announce today that the company has merged with DMI Life Sciences, Inc to form Ampio Pharmaceuticals, Inc. Ampio Pharmaceuticals will trade on the NASDAQ BB under the symbol CHYE. "We have asked FINRA to change our symbol," said Don Wingerter, Ampio Pharmaceuticals' CEO, "and expect to be trading under our new symbol in less than thirty days."
A genetic mutation was found to be associated with Crohn's disease. The discovery was made by international research collaboration and was published in the prestigious journal Science Translational Medicine.
Shire plc, the global specialty biopharmaceutical company, today announced new findings on once-daily INTUNIV (guanfacine) Extended Release Tablets, the first selective alpha-2A agonist approved for the treatment of Attention Deficit Hyperactivity Disorder, at a major psychiatric meeting.
› Verified 6 days ago
Las Vegas Post Acute & Rehabilitation Location: 2832 S. Maryland Parkway, Las Vegas, Nevada 89109 Phone: (702) 735-5848 | |
El Jen Convalescent Hospital And Retirement Center Location: 5538 W Duncan Dr, Las Vegas, Nevada 89130 Phone: (702) 645-2606 | |
Horizon Health And Rehabilitation Center Location: 660 Desert Ln, Las Vegas, Nevada 89106 Phone: (702) 382-5580 | |
Premier Health & Rehabilitation Center Of Lv, Lp Location: 2945 Casa Vegas Street, Las Vegas, Nevada 89169 Phone: (702) 735-7179 | |
Saint Joseph Transitional Rehabilitation Center Location: 2035 W. Charleston Blvd., Las Vegas, Nevada 89102 Phone: (702) 386-7980 | |
Torrey Pines Post Acute And Rehabilitation Location: 1701 S. Torrey Pines Drive, Las Vegas, Nevada 89146 Phone: (702) 871-0005 |